Metagenomic analysis of blood microbiota alterations: insights into HIV progression and immune restoration

Yingjie Chen, Rongqiu Zhang, Jiahong Wen, J. Z. Zhao, Jianmei ZhangFrontiers in Cellular and Infection Microbiology 2025 · DOI

TL;DR

This study utilizes metagenomic sequencing to reveal that HIV infection profoundly disrupts the "blood microbiome," significantly reducing microbial diversity and enriching opportunistic pathogens. While antiretroviral therapy (ART) helps stabilize the immune system, it only partially restores the blood’s microbial balance, suggesting that specific bacterial DNA signatures could serve as novel biomarkers for monitoring HIV progression and treatment efficacy.

What Problem Does This Paper Address?

For a long time, blood was considered a sterile environment. We now know it contains a "circulating microbiome"—primarily fragments of microbial DNA. In HIV patients, the virus attacks the gut-associated lymphoid tissue (GALT), damaging the intestinal barrier and allowing bacteria (or their DNA) to "leak" into the bloodstream, a process called microbial translocation.

While gut microbiome changes in HIV are well-documented, the alterations in the blood microbiota are less understood. The researchers sought to determine if blood microbial signatures could act as a "complementary window" to track how HIV progresses and how well a patient’s immune system recovers during treatment.

Methods

The researchers performed shotgun metagenomic sequencing on blood samples from 91 participants (31 untreated HIV-infected, 30 ART-treated, and 30 healthy controls).

  • Sequencing & Taxonomy: They used the MGISEQ-200RS platform. To identify "who" was in the blood, they employed Kraken2 for taxonomic classification and Bracken for estimating species abundance.
  • Bioinformatics: They calculated alpha-diversity (within-sample richness) and beta-diversity (between-group differences).
  • Statistical Modeling: The team used LEfSe (Linear Discriminant Analysis Effect Size) to find the most "discriminative" species between groups and Spearman correlation to link specific microbes to clinical markers like viral load and the CD4/CD8 T-cell ratio.

Datasets

The study relied on a primary clinical dataset of 91 human participants recruited from the Xiamen Center for Disease Control and Prevention.

  • Newly Introduced: The raw sequencing data has been deposited in the NCBI Sequence Read Archive (SRA) under BioProject accession PRJNA1225636.
  • Reference Genomes: They used the human reference genome (hg19) to filter out host DNA before analyzing the microbial sequences.

Key Insights and Ideas

  • The Diversity Paradox: Unlike some previous studies that suggested translocation might increase blood microbial diversity, this study found that HIV infection significantly decreased alpha-diversity. This suggests that the depletion of beneficial, "commensal" microbes outweighs the influx of new pathogens.
  • Pathogenic Enrichment: HIV-infected blood showed a marked increase in opportunistic pathogens like Pseudomonas aeruginosa and Acinetobacter baumannii. These are often associated with hospital-acquired infections, highlighting the vulnerability of the HIV-positive immune system.
  • ART is a Partial Fix: Antiretroviral therapy successfully suppressed viral loads and improved T-cell counts, but it did not fully restore the blood microbiota to a "healthy" state. Beneficial bacteria like Bifidobacterium longum remained depleted even after treatment.
  • Environmental "Invaders": The researchers detected Azospira species—typically environmental bacteria—only in the HIV group. This suggests that immune suppression allows "niche" organisms to colonize the host that would normally be kept at bay.

Key Results

  • Diversity Loss: The HIV group showed a significant drop in the Shannon index ($p = 9.7 \times 10^{-6}$) and Simpson index ($p = 1.4 \times 10^{-6}$) compared to healthy controls.
  • Viral Load Correlations: Acinetobacter pittii showed a strong positive correlation with viral load ($\rho = 0.623, p < 0.001$), making it a potential indicator of disease severity.
  • Immune Restoration Markers: In patients on ART, the abundance of Acinetobacter junii ($\rho = 0.505$) and Pseudomonas putida ($\rho = -0.452$) correlated with the CD4/CD8 ratio, suggesting these species might track (or even influence) immune recovery.
  • Taxonomic Shifts: In the HIV group, Pseudomonas became the dominant genus, accounting for 63.04% of the total blood microbiota.

Limitations and Future Work

  • DNA vs. Live Bacteria: The study detects microbial DNA, not necessarily viable, living bacteria. It remains unclear if these microbes are active in the blood or just "ghosts" of past translocation events.
  • Cross-Sectional Design: The study looks at a snapshot in time. Longitudinal studies (following the same patients over years) are needed to confirm if these microbial shifts truly predict clinical outcomes.
  • Sample Size and Diversity: The cohort was relatively small and recruited from a single center. The researchers also noted a gender imbalance (more men in the HIV groups), which could be a confounding factor.
  • Mechanistic Gaps: The study identifies correlations but doesn't explain the mechanism of how these specific bacteria interact with the human immune system. Future work should incorporate markers of gut permeability (like zonulin or LPS) to bridge the gap between gut leakage and blood signatures.

Summary updated

Abstract

These findings provide new insights into the interactions between blood microbiota and HIV progression. The identified blood microbiota may serve as potential indicators for evaluating HIV infection status and treatment efficacy, offering a basis for microbial-based diagnostic and therapeutic strategies.
BibTeX
@inproceedings{chen2025metagenomic,
  author = {Yingjie Chen and Rongqiu Zhang and Jiahong Wen and J. Z. Zhao and Jianmei Zhang},
  title = {{Metagenomic analysis of blood microbiota alterations: insights into HIV progression and immune restoration}},
  booktitle = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1619059},
}
Figure